Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial sponsored by the NIH Clinical Center evaluating chemotherapy in patients with acute lymphoblastic leukemia and non-…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Study to Treat Relapsed Follicular Non-Hodgkin's Lymphoma With Radiation and Bexxar [Phase 2]
Phase 2 study evaluating radiation therapy plus Bexxar (tositumomab) for relapsed follicular non-Hodgkin's lymphoma; the trial was terminate…
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Blood Samples to Evaluate Biomarkers of Donor Chimerism
The document summarizes a completed trial examining blood-based biomarkers of donor chimerism. The study involves patients with hematologic …
-
CLINICAL_TRIALS trial_result · 2012-02-14Clinical Trial Update: Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma [Phase 1]
Phase 1 multi-dose escalation trial evaluating the safety and pharmacokinetics of SAR3419 as a single agent in relapsed/refractory B-cell no…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab Pateinets With Aggresive NHL [Phase 1, Phase 2]
The document reports on a CHOP-R-like regimen (cyclophosphamide, doxorubicin, vincristine, prednisone, rituximab) tested in aggressive non-H…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-03Clinical Trial Update: Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma [Phase 3]
Phase 3 trial evaluating BiovaxID, a tumor-derived idiotype vaccine, in follicular lymphoma is ongoing with the trial status listed as unkno…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating Rituximab with high-dose chemotherapy for non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating sirolimus plus tacrolimus for graft-versus-host disease prophylaxis after related stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation [Phase 2]
A Phase 2 study evaluating sirolimus with tacrolimus for graft-versus-host disease prophylaxis after unrelated donor stem cell transplantati…
-
CLINICAL_TRIALS trial_result · 2012-01-26Clinical Trial Update: Study of Iodine-131 Anti-B1 Antibody for Patients With Non Hodgkin's Lymphoma Who Have Previously Received Rituximab [Phase 2]
Phase 2 clinical trial update reporting results for an iodine-131 labeled anti-B1 antibody in Non-Hodgkin lymphoma patients who previously r…
-
CLINICAL_TRIALS trial_result · 2012-01-25Clinical Trial Update: Brown Fat Activity and White Fat Accumulation
A completed clinical trial update from Children's Hospital Los Angeles studied brown fat activity and white fat accumulation in patients wit…
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Functional Assessment of Cancer Therapy - Bone Marrow Transplant
Clinical trial update on Functional Assessment of Cancer Therapy in the bone marrow transplant setting, involving Hodgkin lymphoma and Non-H…
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases
This clinical trial update notes prospective data collection of newly diagnosed Hodgkin lymphoma and Non-Hodgkin lymphoma cases at King Fais…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL). [Phase 3]
Phase 3 trial evaluating lenalidomide as maintenance therapy after first-line chemotherapy in mantle cell lymphoma; the study was terminated…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating peripheral stem cell transplantation in patients with relapsed low- or intermediate-grade Non-Hodgkin lymphoma has …
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan
A completed Japanese post-marketing surveillance study evaluated the adequacy of image interpretation criteria for Zevalin (ibritumomab tiux…
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
Update on prognosis for patients with aggressive B-cell lymphoma treated with a rituximab-containing anthracycline regimen, based on complet…
-
CLINICAL_TRIALS trial_result · 2011-11-22Clinical Trial Update: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL) [Phase 1]
Phase I multicenter dose-escalation study of CAT-8015 in patients with Non-Hodgkin lymphoma; sponsored by MedImmune LLC, with the trial stat…
-
FDA approval · 2011-11-18FDA Approved: ZEVALIN — Supplemental Application (Acrotech Biopharma Inc)
FDA approved a supplemental application for ZEVALIN (ibritumomab tiuxetan) submitted by Acrotech Biopharma Inc.
-
FDA label_change · 2011-10-28FDA Approved: LEUKERAN — Supplemental Application (Waylis Therapeutics LLC)
FDA supplemental application for Leukeran (chlorambucil) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma [Phase 2]
Phase 2 open-label trial evaluating Brentuximab Vedotin in systemic anaplastic large cell lymphoma, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating a recombinant human-mouse chimeric anti-CD20 monoclonal antibody for diffuse large B-cell lymphoma (a type of non…
-
CLINICAL_TRIALS research · 2011-10-13Clinical Trial Update: Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma [Phase 2]
A multicenter Phase II pilot trial assessing the efficacy and safety of LR-CHOP21 in elderly patients with untreated diffuse large B-cell ly…
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas [Phase 1, Phase 2]
A clinical trial update reports the Phase 1/2 study of dulanermin in combination with rituximab for follicular and other low-grade CD20+ non…